Form D — NEURONA THERAPEUTICS, INC

0001443321-25-000001 · filed Apr 4, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $101,711,423
Reported amount sold: $101,711,423
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: NEURONA THERAPEUTICS, INC
CIK: 1443321
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 170 HARBOR WAY
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-676-4182

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Cory Nicholas · Executive Officer

South San Francisco, CA Find on LinkedIn ↗
James Stutz · Executive Officer

South San Francisco, CA Find on LinkedIn ↗
Tim Kutzkey · Director

South San Francisco, CA Find on LinkedIn ↗
Leo Guthart · Director

South San Francisco, CA Find on LinkedIn ↗
Ray Kelleher · Director

South San Francisco, CA Find on LinkedIn ↗
Brad Margus · Director

South San Francisco, CA Find on LinkedIn ↗
Erica Whittaker · Director

South San Francisco, CA Find on LinkedIn ↗
Peter Svennilson · Director

South San Francisco, CA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗